784 filings
Page 17 of 40
8-K
CRVO
CervoMed Inc
19 Nov 19
Chief Scientific Officer Dr. John Gainer to Present at Inaugural Glioblastoma Drug Development Summit
4:49pm
8-K
CRVO
CervoMed Inc
15 Nov 19
Diffusion Pharmaceuticals Announces Closing of $4.0 Million Public Offering
4:06pm
424B4
CRVO
CervoMed Inc
15 Nov 19
Prospectus supplement with pricing info
12:00am
EFFECT
CRVO
CervoMed Inc
14 Nov 19
Notice of effectiveness
12:15am
8-K
CRVO
CervoMed Inc
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
S-1/A
CRVO
CervoMed Inc
IPO registration (amended)
13 Nov 19
12:00am
8-K
CRVO
CervoMed Inc
12 Nov 19
Diffusion Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
8:19am
S-1/A
CRVO
CervoMed Inc
IPO registration (amended)
8 Nov 19
5:20pm
10-Q
2019 Q3
CRVO
CervoMed Inc
Quarterly report
8 Nov 19
4:05pm
CORRESP
CRVO
CervoMed Inc
8 Nov 19
Correspondence with SEC
12:00am
CORRESP
CRVO
CervoMed Inc
30 Oct 19
Correspondence with SEC
12:00am
S-1/A
CRVO
CervoMed Inc
IPO registration (amended)
28 Oct 19
4:50pm
CORRESP
CRVO
CervoMed Inc
28 Oct 19
Correspondence with SEC
12:00am
CORRESP
CRVO
CervoMed Inc
28 Oct 19
Correspondence with SEC
12:00am
UPLOAD
CRVO
CervoMed Inc
22 Oct 19
Letter from SEC
12:00am
S-1
CRVO
CervoMed Inc
IPO registration
16 Oct 19
5:16pm
424B3
CRVO
CervoMed Inc
10 Oct 19
Prospectus supplement
4:54pm
EFFECT
CRVO
CervoMed Inc
9 Oct 19
Notice of effectiveness
12:15am
CORRESP
CRVO
CervoMed Inc
4 Oct 19
Correspondence with SEC
12:00am
S-1/A
CRVO
CervoMed Inc
IPO registration (amended)
27 Sep 19
10:29am